|
ISRCTN
|
ISRCTN71577271
|
|
ClinicalTrials.gov identifier
|
|
|
Public title
|
Development, implementation and evaluation of an integrated follow-up programme for people with cutaneous malignant melanoma
|
|
Scientific title
|
|
|
Acronym
|
N/A
|
|
Serial number at source
|
C10673/A3912
|
|
Study hypothesis
|
Programmes of integrated follow-up co-ordinate activities and resources between primary and secondary care to ensure effective on-going care for patients with specific conditions. This proposal is to develop, implement and evaluate a primary care based integrated follow-up programme for people with cutaneous malignant melanoma. A rigorously evaluated programme for cutaneous malignant melanoma could provide a model for low-tech, efficient, effective and sustainable follow-up programme. Malignant melanoma and primary care have been chosen for the model for several reasons. Melanoma affects both sexes with a disproportionate impact on young people. Most individuals survive for prolonged periods but can experience a recurrence at any time making careful follow-up important. Follow-up consists mainly of clinical examination in contrast to other cancers that need invasive follow-up procedures. Most general practices will have small numbers of patients with melanoma. While this is likely to facilitate primary care based follow-up because of comparatively light workload and resource requirements, it creates challenges in terms of gaining and maintaining expertise.
|
|
Lay summary
|
Not provided at time of registration
|
|
Ethics approval
|
Not provided at time of registration
|
|
Study design
|
Randomised controlled trial
|
|
Countries of recruitment
|
United Kingdom
|
|
Disease/condition/study domain
|
Cutaneous Malignant Melanoma
|
|
Participants - inclusion criteria
|
People previously treated for cutaneous malignant melanoma.
|
|
Participants - exclusion criteria
|
1. Non cutaneous melanoma
2. Active recurrence or a recurrence within the last 12 months
3. Terminally ill
4. Mentally ill
5. If their general practitioner believes them to be otherwise unsuitable for participation in the study
|
|
Anticipated start date
|
01/04/2005
|
|
Anticipated end date
|
30/09/2006
|
|
Status of trial
|
Completed |
|
Patient information material
|
|
|
Target number of participants
|
150
|
|
Interventions
|
Integrated primary care based follow-up programme for cutaneous malignant melanoma. Intervention comprises general practitioner training, central appointments database, patient education programme, protocol driven reviews in primary care, rapid access pathway to secondary care.
The control group continue to attend follow-up at the Joint Melanoma Clinic, Aberdeen Royal Infirmary. This would be termed 'usual care' as it is the current standard treatment for people treated for melanoma.
|
|
Primary outcome measure(s)
|
Patient satisfaction and adherence to guidelines
|
|
Secondary outcome measure(s)
|
1. Psychological and physical well-being
2. Costs to patients and health services
3. Processes of care
|
|
Sources of funding
|
Cancer Research UK (CRUK) (UK) (ref: C10673/A3912)
|
|
Trial website
|
|
|
Publications
|
2010 patient satisfaction results in http://www.ncbi.nlm.nih.gov/pubmed/20461089
|
|
Contact name
|
Dr
Peter
Murchie
|
|
Address
|
University of Aberdeen
Department of General Practice and Primary Care
Foresterhill Health Centre
Westburn Road
|
|
City/town
|
Aberdeen
|
|
Zip/Postcode
|
AB25 2AY
|
|
Country
|
United Kingdom
|
|
Sponsor
|
University of Aberdeen (UK)
|
|
Address
|
King's College
|
|
City/town
|
Aberdeen
|
|
Zip/Postcode
|
AB24 3FX
|
|
Country
|
United Kingdom
|
|
Tel
|
+44 (0)1224-272000
|
|
Email
|
sras@abdn.ac.uk
|
|
Sponsor website:
|
http://www.abdn.ac.uk/idx.php
|
|
Date applied
|
25/08/2005
|
|
Last edited
|
18/01/2012
|
|
Date ISRCTN assigned
|
19/10/2005
|
